David Ferrera and Robyn Maguire Analyze 3D Printing in the Health Care Industry in Additive Manufacturing TodayPrint PDF
David Ferrera, partner in Nutter’s Litigation Department and chair of the firm’s Product Liability and Toxic Tort Litigation practice group, and Robyn Maguire, partner in Nutter’s Litigation Department and a member of the firm’s Product Liability and Toxic Tort Litigation and Business Litigation practice groups, were featured in a Q&A about 3D printing in Additive Manufacturing Today. In the article, “Heath Care 3D Printing Q&A,” David and Robyn weigh in on the revolution of 3D printing in the health care industry, including how the FDA will regulate 3D manufactured medical devices, and analyze the liability of 3D manufactured medical devices.
According to David and Robyn, liability remains a somewhat open question, because 3D printing is both relatively novel and extremely intricate. It’s likely that at first courts will try to apply the same theories of liability used to evaluate tangible things produced using traditional manufacturing processes—by examining the design, manufacture, and distribution of the defective product. However, 3D printing turns the traditional manufacturing process on its head.